Cargando…
Limited accessibility to designs and results of Japanese large-scale clinical trials for cardiovascular diseases
BACKGROUND: Clinical evidence is important for improving the treatment of patients by health care providers. In the study of cardiovascular diseases, large-scale clinical trials involving thousands of participants are required to evaluate the risks of cardiac events and/or death. The problems encoun...
Autores principales: | Sawata, Hiroshi, Ueshima, Kenji, Tsutani, Kiichiro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096578/ https://www.ncbi.nlm.nih.gov/pubmed/21492452 http://dx.doi.org/10.1186/1745-6215-12-96 |
Ejemplares similares
-
How Can the Evidence from Global Large-scale Clinical Trials for Cardiovascular Diseases be Improved?
por: Sawata, Hiroshi, et al.
Publicado: (2011) -
Funding and infrastructure among large-scale clinical trials examining cardiovascular diseases in Japan: evidence from a questionnaire survey
por: Sawata, Hiroshi, et al.
Publicado: (2011) -
Use of Kampo Diagnosis in Randomized Controlled Trials of Kampo Products in Japan: A Systematic Review
por: Motoo, Yoshiharu, et al.
Publicado: (2014) -
Use of Complementary and Alternative Medicine in Japan: A Cross-sectional Internet Survey Using the Japanese Version of the International Complementary and Alternative Medicine Questionnaire
por: Motoo, Yoshiharu, et al.
Publicado: (2019) -
Compliance of Clinical Trial Protocols for Foods with Function Claims (FFC) in Japan: Consistency between Clinical Trial Registrations and Published Reports
por: Kamioka, Hiroharu, et al.
Publicado: (2021)